Table of Contents

company-logo

Curative Biotechnology, Inc. operates as a development-stage biomedical company. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease. Its pipeline candidates include IMT504, a novel immune therapy to treat rabies and an adjuvant for vaccines; CUBT906, a fully humanized CD56 monoclonal antibody carrying a pyrrolobenzodiazepine dimer directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor; and Metformin Reformulation for the treatment of degenerative eye disease. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine. The company was formerly known as Connectyx Technologies Holdings Group, Inc. and changed its name to Curative Biotechnology, Inc. in November 2020. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Boca Raton, Florida.

Curative Biotechnology Dividend Announcement

• Curative Biotechnology does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Curative Biotechnology dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Curative Biotechnology Dividend History

Curative Biotechnology Dividend Yield

Curative Biotechnology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Curative Biotechnology stock? Use our calculator to estimate your expected dividend yield:

Curative Biotechnology Financial Ratios

P/E ratio-1.22
PEG ratio-0.01
P/B ratio-1.44
ROE124.31%
Payout ratio0.00%
Current ratio0.07
Quick ratio0.07
Cash Ratio0.05

Curative Biotechnology Dividend FAQ

Does Curative Biotechnology stock pay dividends?
Curative Biotechnology does not currently pay dividends to its shareholders.
Has Curative Biotechnology ever paid a dividend?
No, Curative Biotechnology has no a history of paying dividends to its shareholders. Curative Biotechnology is not known for its dividend payments.
Why doesn't Curative Biotechnology pay dividends?
There are several potential reasons why Curative Biotechnology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Curative Biotechnology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Curative Biotechnology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Curative Biotechnology a dividend aristocrat?
Curative Biotechnology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Curative Biotechnology a dividend king?
Curative Biotechnology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Curative Biotechnology a dividend stock?
No, Curative Biotechnology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Curative Biotechnology stocks?
To buy Curative Biotechnology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Curative Biotechnology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.